Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$213M |
| 2 |
AVLR
Avalara, Inc.
AVLR
|
+$183M |
| 3 |
Baxter International
BAX
|
+$173M |
| 4 |
3M
MMM
|
+$172M |
| 5 |
Analog Devices
ADI
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$197M |
| 2 |
TransDigm Group
TDG
|
+$181M |
| 3 |
Apple
AAPL
|
+$148M |
| 4 |
Oracle
ORCL
|
+$133M |
| 5 |
ACC
American Campus Communities, Inc.
ACC
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.6% |
| 2 | Technology | 10.81% |
| 3 | Financials | 10.76% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
CALL
Cummins
CMI
$78.8B
| $2.28M | 0.01% |
11,200
+8,400
| +300% | +$1.79M |
|
|
1402
PUT
Cummins
CMI
$78.8B
| $2.28M | 0.01% |
11,200
+8,400
| +300% | +$1.79M |
|
1403
Murphy Oil
MUR
$4.96B
| $2.28M | 0.01% |
64,815
-904,533
| -93% | -$31.3M |
|
|
ARCK
1404
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock
ARCK
| $2.28M | 0.01% |
225,005
+25,005
| +13% | +$252K |
|
|
CADE
1405
DELISTED
Cadence Bank
CADE
| $2.23M | 0.01% |
+87,856
| New | +$2.26M |
|
1406
Celanese
CE
$4.89B
| $2.23M | 0.01% |
24,682
+15,763
| +177% | +$1.73M |
|
|
GNAC
1407
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
| $2.23M | 0.01% |
225,225
| – | – |
|
1408
CALL
Wayfair
W
$14.3B
| $2.22M | 0.01% |
+68,300
| New | +$3.61M |
|
1409
Intellia Therapeutics
NTLA
$1.89B
| $2.22M | 0.01% |
+39,689
| New | +$2.46M |
|
1410
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.03B
| $2.22M | 0.01% |
+24,191
| New | +$2.53M |
|
|
ARGO
1411
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.21M | 0.01% |
+114,988
| New | +$3.01M |
|
1412
Fresenius Medical Care
FMS
$12.5B
| $2.21M | 0.01% |
+157,257
| New | +$2.97M |
|
|
FLYA
1413
DELISTED
SOAR Technology Acquisition Corp.
FLYA
| $2.21M | 0.01% |
214,050
| – | – |
|
|
JUN
1414
DELISTED
Juniper II Corp.
JUN
| $2.2M | 0.01% |
220,971
| – | – |
|
1415
AEON Biopharma
AEON
$10.6M
| $2.2M | 0.01% |
3,106
+328
| +12% | +$232K |
|
1416
Exponent
EXPO
$3.33B
| $2.2M | 0.01% |
25,094
+13,950
| +125% | +$1.32M |
|
1417
IMAX
IMAX
$2.96B
| $2.18M | 0.01% |
+154,359
| New | +$2.48M |
|
|
VECT
1418
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $2.17M | 0.01% |
362,538
-2,994
| -0.8% | -$16.3K |
|
1419
Canadian Solar
CSIQ
$970M
| $2.17M | 0.01% |
+58,320
| New | +$2.22M |
|
1420
Alarm.com
ALRM
$2.79B
| $2.17M | 0.01% |
33,452
+3,741
| +13% | +$257K |
|
1421
Ares Capital
ARCC
$14.3B
| $2.17M | 0.01% |
128,528
+89,385
| +228% | +$1.73M |
|
1422
CALL
GE Aerospace
GE
$363B
| $2.17M | 0.01% |
56,178
+40,127
| +250% | +$1.76M |
|
1423
XPeng
XPEV
$11.1B
| $2.16M | 0.01% |
+180,829
| New | +$3.89M |
|
|
AIRC
1424
DELISTED
Apartment Income REIT Corp.
AIRC
| $2.16M | 0.01% |
55,963
+47,050
| +528% | +$1.99M |
|
1425
State Street SPDR S&P Biotech ETF
XBI
$11.8B
| $2.16M | 0.01% |
27,196
-67,102
| -71% | -$5.66M |
|
Similar funds
Dmitry Balyasny's Q3 2022 Portfolio in Review
As of Q3 2022, Dmitry Balyasny held 3,497 positions worth $32.6B, up 6.1% from $30.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Dmitry Balyasny deployed $3.25B of net new capital in Q3 2022, opening 824 new positions and adding to 816 existing holdings. Its largest new stake was Baxter International: 2,869,138 shares worth $155M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Boeing, an estimated $197M trimmed.
- Dmitry Balyasny's largest Q3 2022 buy was Baxter International: 2,869,138 shares worth $155M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $213M increase.
- Dmitry Balyasny's biggest Q3 2022 reduction was Boeing, cutting an estimated $197M.
- Dmitry Balyasny fully exited TransDigm Group in Q3 2022, selling an estimated $181M.
- Dmitry Balyasny's ten largest holdings make up 9% of its $32.6B portfolio in Q3 2022.
- Dmitry Balyasny opened 824 new positions and closed 693 in Q3 2022.
- Dmitry Balyasny's portfolio value rose 6.1% quarter-over-quarter to $32.6B.
Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.